Efficacy and Tolerance of a Follow-On Formula Fed to Children From 12-48 Months of Age in Salvador, Bahia, Brazil
1 other identifier
interventional
250
1 country
1
Brief Summary
The purpose is to determine if the consumption of study product has an effect on acute respiratory infections and/or diarrheal disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2011
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 31, 2011
CompletedStudy Start
First participant enrolled
September 1, 2011
CompletedFirst Posted
Study publicly available on registry
September 9, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2012
CompletedDecember 6, 2012
December 1, 2012
8 months
August 31, 2011
December 5, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
Episodes of acute respiratory infections and diarrheal disease
28 weeks
Secondary Outcomes (10)
Occurrence of allergic manifestations
28 weeks
Systemic antibiotic use
28 weeks
Duration of acute respiratory infection and diarrheal disease
28 weeks
Changes in stool patterns
28 weeks
Fecal and serum immune markers
28 weeks
- +5 more secondary outcomes
Study Arms (2)
Cow's Milk
PLACEBO COMPARATORPowdered Whole Cow's Milk
Follow-On Formula
EXPERIMENTALPowdered Follow-On Formula with added long-chain Polyunsaturated fatty acid, prebiotics, and polysaccharide
Interventions
Powdered Follow-On Formula with added long-chain Polyunsaturated fatty acid, prebiotics, and polysaccharide
Eligibility Criteria
You may qualify if:
- Child 12-48 months of age
- Has consumed cow's milk or a cow's milk-based beverage during the 48 hours prior to randomization
- Signed informed consent
You may not qualify if:
- Child who is receiving predominantly breast-milk
- Child who received any food product or supplement containing probiotics or prebiotics in the 15 days prior to randomization
- Child with allergy to gluten or serious concurrent illness that will interfere in the general management of the child
- Child with diarrhea or acute respiratory infection during the 48 hours prior to randomization
- Child's z-score of weight for length/height \< -3 according to World Health Organization criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mead Johnson Nutritionlead
- Federal University of Bahiacollaborator
Study Sites (1)
Universidade Federal da Bahia, Hospital Universitário Prof. Edgard Santos Complexo HUPES, Centro Pediátrico Professor Hossanah Oliveira, Centro da Pesquisas Fima Lifshitz, Rua Augusto Viana s/n Canela
Salvador, Estado de Bahia, CEP 401 10-060, Brazil
Related Publications (1)
Pontes MV, Ribeiro TC, Ribeiro H, de Mattos AP, Almeida IR, Leal VM, Cabral GN, Stolz S, Zhuang W, Scalabrin DM. Cow's milk-based beverage consumption in 1- to 4-year-olds and allergic manifestations: an RCT. Nutr J. 2016 Feb 27;15:19. doi: 10.1186/s12937-016-0138-0.
PMID: 26920136DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 31, 2011
First Posted
September 9, 2011
Study Start
September 1, 2011
Primary Completion
May 1, 2012
Study Completion
May 1, 2012
Last Updated
December 6, 2012
Record last verified: 2012-12